1-O-(α-D-galactopyranosyl)-N-hexacosanoylphytosphingosine Uses, Dosage, Side Effects and more
KRN7000 has been used in trials studying the treatment of Lung Cancer, Chronic Hepatitis C, Hepatitis B, Chronic, Unspecified Adult Solid Tumor, Protocol Specific, and Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT.
| Attribute | Details |
|---|---|
| Trade Name | 1-O-(α-D-galactopyranosyl)-N-hexacosanoylphytosphingosine |
| Generic | KRN-7000 |
| KRN-7000 Other Names | 1-O-(α-D-galactopyranosyl)-N-hexacosanoylphytosphingosine |
| Type | |
| Formula | C50H99NO9 |
| Weight | Average: 858.3224 Monoisotopic: 857.731983771 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
